Cellular Senescence, Neurological Function, and Redox State
The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Abstract
SIGNIFICANCE: Cellular senescence, characterized by permanent cell cycle arrest, has been extensively studied in mitotic cells such as fibroblasts. However, senescent cells have also been observed in the brain. Even though it is recognized that cellular energetic metabolism and redox homeostasis are perturbed in the aged brain and neurodegenerative diseases (NDDs), it is still unknown which alterations in the overall physiology can stimulate cellular senescence induction and their relationship with the former events. Recent Advances: Recent findings have shown that during prolonged inflammatory and pathologic events, the blood-brain barrier could be compromised and immune cells might enter the brain; this fact along with the brain's high oxygen dependence might result in oxidative damage to macromolecules and therefore senescence induction. Thus, cellular senescence in different brain cell types is revised here. CRITICAL ISSUES: Most information related to cellular senescence in the brain has been obtained from research in glial cells since it has been assumed that the senescent phenotype is a feature exclusive to mitotic cells. Nevertheless, neurons with senescence hallmarks have been observed in old mouse brains. Therefore, although this is a controversial topic in the field, here we summarize and integrate the observations from several studies and propose that neurons indeed senesce. FUTURE DIRECTIONS: It is still unknown which alterations in the overall metabolism can stimulate senescence induction in the aged brain, what are the mechanisms and signaling pathways, and what is their relationship to NDD development. The understanding of these processes will expose new targets to intervene age-associated pathologies.-Antioxid. Redox Signal. 28, 1704-1723.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917 · cited 1×
“RS occurs due to telomere shortening after each round of replication; when telomeres reach a critical size, a persistent DNA damage response (DDR) is activated, culminating in proliferation arrest (20, 38).”
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584 · cited 1×
“…delay in cellular senescence induction when the cells are treated with antioxidants, such as Trolox (168), phenolic diterpenes (22), and polyphenols (148), ascorbic acid (85), melatonin (183), and other molecules that modify redox state such as rapamycin (96) and resveratrol (74) or sirtinol (107).”
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · cited 1×
“In both, quiescence and senescence, cell cycle arrest is controlled by cyclin-dependent kinase inhibitors (CDKIs); but while quiescent cells are arrested in G 0 by p27/CDKN1B, in senescent cells, proliferation is inhibited by p21/CDKN1A and/or p16/CDKN2A (34, 122, 184) (Fig.”
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287 · cited 1×
“Increased risk for type 2 diabetes has been linked with specific WNT component modifications (65).”
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 2×
“The phosphorylation induces a conformational change in pRB, which abrogates its binding to E2F, resulting in transcription of required genes to start DNA replication and cell cycle progression (120).”
A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2784 · Cited by 2,278 · cited 1×
“Positive consequences include the tumor suppressor effect (25), along with wound healing and tissue regeneration (42), embryonic tissue remodeling(118,156) and immune system activation (1).”
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
Rodier, F., Coppé, J.-P., Patil, C. K., Hoeijmakers, W. A. M., Muñoz, D. P., Raza, S. R., Freund, A., Campeau, E., Davalos, A. R., & Campisi, J. (2009) · Nature Cell Biology · doi:10.1038/ncb1909 · Cited by 2,232
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086 · cited 3×
“Its regulation is being addressed by established transcription factors associated with the inflammatory response such as the nuclear factor j B (NF-j B) and CCAAT/enhancer-binding protein b (C/EBP b ) (2, 89).”
Four faces of cellular senescence
Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,070 · cited 6×
“…related to undesired outcomes include age-related illnesses, cancer and NDD (11), tissue disruption and dysfunction (55), chronic inflammation (56, 137), proliferation induction and accelerated tumor growth (24, 88), angiogenesis (129), and differentiation and epithelium– mesenchymal transition…”
InfluentialAn Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Transcriptional control of human p53-regulated genes
Riley, T., Sontag, E., Chen, P., & Levine, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2395 · Cited by 1,921 · cited 1×
“…are checkpoint kinases, CHK2 and CHK1, respectively, which after being activated by phosphorylation, in turn activate the transcription factor and tumor suppressor p53 (76, 136), which regulates the expression of the cell cycle inhibitor p21/CDKN1A, a major participant during cellular arrest.”
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821
Chemokine signaling via the CXCR2 receptor reinforces senescence
Acosta, J. C., O'Loghlen, A., Banito, A., Guijarro, M. V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.038 · Cited by 1,801 · cited 3×
“C/EBPβ depletion in epithelial cells and fibroblasts decreased IL‐6 and IL‐8 expression (89) and NF‐κB inhibition significantly diminished ENA‐78, NAP‐2, MCP‐1, MCP‐ 4, MIP‐3 and some members of the GRO family (2).”
InfluentialMicroglial interactions with synapses are modulated by visual experience
Tremblay, M.-È., Lowery, R. L., & Majewska, A. K. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000527 · Cited by 1,542 · cited 1×
“In healthy brain, the microglia are in a quiescent state, but even in this state, they have a fundamental role in monitoring synapse functionality, regulating neuronal activity, and neurogenesis (166).”
Senescence-associated β-galactosidase is lysosomal β-galactosidase.
Lee, B. Y., Han, J. A., Im, J. S., Morrone, A., Johung, K., Goodwin, E. C., Kleijer, W. J., DiMaio, D., & Hwang, E. S. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00199.x · Cited by 1,444
Programmed cell senescence during mammalian embryonic development
Muñoz-Espín, D., Cañamero, M., Maraver, A., Gómez-López, G., Contreras, J., Murillo-Cuesta, S., Rodríguez-Baeza, A., Varela-Nieto, I., Ruberte, J., Collado, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.019 · Cited by 1,428
Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice
Hickman, S. E., Allison, E. K., & El Khoury, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0616-08.2008 · Cited by 1,329 · cited 1×
“Aged microglia change their surface antigen pattern by upregulating MHCII, CD11b, CD11c, and CD68, as well as the pattern recognition receptors, Toll-like receptor 4 (TLR4), CD14, and scavenger receptors (73, 97, 178), all of them related to the activated microglial phenotype (124).”
Astrocytes are active players in cerebral innate immunity
Farina, C., Aloisi, F., & Meinl, E. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.01.005 · Cited by 1,304 · cited 5×
“SASP-secreted factors such as IL-6, have shown detrimental effects in neurons (19, 77), but others, as neural growth factor or insulin-like growth factor-1 (IGF-1) secreted by astrocytes at early stages, havebeneficialeffects onneurons (51).”
InfluentialMitogen-Activated Protein Kinases and Reactive Oxygen Species: How Can ROS Activate MAPK Pathways?
Son, Y., Cheong, Y.-K., Kim, N.-H., Chung, H.-T., Kang, D. G., & Pae, H.-O. (2011) · Journal of Signal Transduction · doi:10.1155/2011/792639 · Cited by 1,219 · cited 1×
“Inter-estingly, MAPK pathways have been shown to be activated not only by receptor ligand interactions but also by ROS (152, 153), therefore the use of antioxidants to regulate p38 (175) or to modulate redox state (40) and decrease proinflammatory SASP components is also explored.”
Laberge, R.-M., Sun, Y., Orjalo, A. V., Patil, C. K., Freund, A., Zhou, L., Curran, S. C., Davalos, A. R., Wilson-Edell, K. A., Liu, S., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3195 · Cited by 1,160 · cited 2×
“In the first one, mTOR impacted again in the IL-1 a /NF-j B pathway (91), and in the second report, rapamycin is proposed to act by regulating p38/MAPK and MAPK-activated protein kinase 2 (MAP-KAPK2) through eukaryotic translation factor 4E-binding protein (4EBP1) (72).”
Senescence in tumours: evidence from mice and humans
Collado, M., & Serrano, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2772 · Cited by 1,124 · cited 2×
“…senescence occurs both in vitro and in vivo (46) and it has been associated with many biological processes such as aging (21), tumor suppression and promotion (23, 137), chronic inflammation (20), embryonic development (118, 156), and recently with neurodegenerative diseases (NDDs) (11, 13, 35).”
Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts
Parrinello, S., Samper, E., Krtolica, A., Goldstein, J., Melov, S., & Campisi, J. (2003) · Nature Cell Biology · doi:10.1038/ncb1024 · Cited by 1,116
Freund, A., Patil, C. K., & Campisi, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.69 · Cited by 1,039 · cited 1×
“(57).”
Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6.
Campbell, I. L., Abraham, C. R., Masliah, E., Kemper, P., Inglis, J. D., Oldstone, M. B., & Mucke, L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10061 · Cited by 1,006
The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4.
Kang, C., Xu, Q., Martin, T. D., Li, M. Z., Demaria, M., Aron, L., Lu, T., Yankner, B. A., Campisi, J., & Elledge, S. J. (2015) · Science · doi:10.1126/science.aaa5612 · Cited by 982 · cited 2×
“Recently, SASP production has also been related to autophagy, and the Globin transcription factor 4 (GATA4) has also been proposed as an SASP regulator (82).”
Xu, M., Tchkonia, T., Ding, H., Ogrodnik, M., Lubbers, E. R., Pirtskhalava, T., White, T. A., Johnson, K. O., Stout, M. B., Mezera, V., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1515386112 · Cited by 915 · cited 1×
“JAK/STAT pathway has also been involved in SASP regulation since inhibition of this pathway decreases as well the expression of several SASP components (176).”
Senescence-messaging secretome: SMS-ing cellular stress
Kuilman, T., & Peeper, D. S. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2560 · Cited by 909 · cited 1×
“Another SASP activity is to induce paracrine senescence to neighboring cells (90).”
Oxidative stress in Alzheimer’s disease
Chen, Z., & Zhong, C. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1423-y · Cited by 797 · cited 1×
“The deregulation of neuronal mitochondrial fission–fusion processes could also play a fundamental role in these pathologies (31, 150).”
mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype
Herranz, N., Gallage, S., Mellone, M., Wuestefeld, T., Klotz, S., Hanley, C. J., Raguz, S., Acosta, J. C., Innes, A. J., Banito, A., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3225 · Cited by 788 · cited 1×
“In the first one, mTOR impacted again in the IL-1 a /NF-j B pathway (91), and in the second report, rapamycin is proposed to act by regulating p38/MAPK and MAPK-activated protein kinase 2 (MAP-KAPK2) through eukaryotic translation factor 4E-binding protein (4EBP1) (72).”
Oxidative DNA damage and senescence of human diploid fibroblast cells.
Chen, Q., Fischer, A., Reagan, J. D., Yan, L. J., & Ames, B. N. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4337 · Cited by 720 · cited 1×
“Albeit 8‐oxo‐7,8‐dihydro‐2 ́‐deoxyguanosine (8‐oxodGuo) is a selective marker of oxidative DNA damage (71), whose quantification has gained popularity since it is one of the most abundant oxidative DNA lesions that correlates with mutagenesis, carcinogenesis and aging (29,102).”
Toussaint, O., Medrano, E. E., & von Zglinicki, T. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00180-7 · Cited by 713
Microglia derived from aging mice exhibit an altered inflammatory profile
Sierra, A., Gottfried‐Blackmore, A. C., McEwen, B. S., & Bulloch, K. (2007) · Glia · doi:10.1002/glia.20468 · Cited by 688 · cited 2×
“Moreover, aged microglia are over-responsive, they have an enhanced IL-6, IL-1 b , and ROS production in response to lipopolysaccharide (LPS) than younger microglia (149, 161).”
Moiseeva, O., Deschênes‐Simard, X., St‐Germain, E., Igelmann, S., Huot, G., Cadar, A. E., Bourdeau, V., Pollak, M. N., & Ferbeyre, G. (2013) · Aging Cell · doi:10.1111/acel.12075 · Cited by 654
Metabolic Syndrome, Aging and Involvement of Oxidative Stress
Bonomini, F., Rodella, L. F., & Rezzani, R. (2015) · Aging and Disease · doi:10.14336/ad.2014.0305 · Cited by 599 · cited 1×
“The aging process is accelerated when metabolic and cardiovascular diseases are present, and the risk of illness increases with age (17).”
Jurk, D., Wang, C., Miwa, S., Maddick, M., Korolchuk, V., Tsolou, A., Gonos, E. S., Thrasivoulou, C., Jill Saffrey, M., Cameron, K., et al. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00870.x · Cited by 598
Astrocyte Senescence as a Component of Alzheimer’s Disease
Bhat, R., Crowe, E. P., Bitto, A., Moh, M., Katsetos, C. D., Garcia, F. U., Johnson, F. B., Trojanowski, J. Q., Sell, C., & Torres, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045069 · Cited by 586 · cited 8×
“Senescent cells have recently been observed in CNS (11, 13, 35), so understanding their participation is very important to comprehend brain deterioration during aging as well as the progression of various NDDs.”
InfluentialSelf-citationLiu, D., & Hornsby, P. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3452 · Cited by 499
Many roads lead to oncogene-induced senescence
Courtois-Cox, S., Jones, S. L., & Cichowski, K. (2008) · Oncogene · doi:10.1038/sj.onc.1210950 · Cited by 397 · cited 11×
“A key role for mechanistic target of rapamycin (mTOR) signaling during OIS in human fibroblasts has also been suggested.”
InfluentialRole of microglia in CNS inflammation
Graeber, M. B., Li, W., & Rodriguez, M. L. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.08.033 · Cited by 392 · cited 1×
“Microglia can respond to a variety of stimuli, such as parasitic, viral, or bacterial infection, triggering a classical inflammatory response (64).”
Jones, D. P., Mody, V. C., Carlson, J. L., Lynn, M. J., & Sternberg, P. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01040-7 · Cited by 392 · cited 1×
“Conversely, an acknowledged common feature in all described types of senescence is a shift to a pro-oxidant redox state (45, 80, 108, 116), as illustrated in the signaling pathways described above.”
Salminen, A., Ojala, J., Kaarniranta, K., Haapasalo, A., Hiltunen, M., & Soininen, H. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07738.x · Cited by 333 · cited 2×
“Therefore, the occurrence of senescent astrocytes in the brain was predicted to contribute to brain decline during aging and accelerate neurological pathologies through the SASP (11, 36, 141).”
Streit, W. J., Xue, Q.-S., Tischer, J., & Bechmann, I. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0142-6 · Cited by 317 · cited 1×
“It has also been reported that in aged organisms, microglia undergo structural abnormalities characterized by cell senescence phenotype mainly characterized by cytoplasmic degeneration (157).”
Control of the Reversibility of Cellular Quiescence by the Transcriptional Repressor HES1
Sang, L., Coller, H. A., & Roberts, J. M. (2008) · Science · doi:10.1126/science.1155998 · Cited by 313 · cited 2×
“Quiescent cells are in a reversible cell cycle arrest, able to respond to mitotic stimuli; the expression of the transcriptional repressor HES1 inhibits the acquisition of the senescent phenotype (142).”
Astrocytic Control of Biosynthesis and Turnover of the Neurotransmitters Glutamate and GABA
Schousboe, A., Bak, L. K., & Waagepetersen, H. S. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00102 · Cited by 303
Coppé, J.-P., Patil, C. K., Rodier, F., Sun, Y., Muñoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P.-Y., & Campisi, J. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060301 · Cited by 302 · cited 6×
“Cellular senescence is accompanied by the secretion of a diverse array of molecules such as cytokines, chemo-kines, growth factors, and proteases among others, known as senescence-associated secretory phenotype (SASP) (2, 25, 89), which has pleiotropic effects that will be discussed later.”
InfluentialNeuroinflammation in Neurodegenerative Disorders-a Review
Schain, M., & Kreisl, W. C. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0733-2 · Cited by 301
Astle, M. V., Hannan, K. M., Ng, P. Y., Lee, R. S., George, A. J., Hsu, A. K., Haupt, Y., Hannan, R. D., & Pearson, R. B. (2012) · Oncogene · doi:10.1038/onc.2011.394 · Cited by 295 · cited 2×
“Inhibition Inhibition of mTOR complex 1 (mTORC1) by rapamycin, or silencing mTOR or Raptor with shRNAs, delays RS and OIS, whereas mTOR complex 2 (mTORC2) inhibition does not (8, 86).”
Bachstetter, A. D., Xing, B., de Almeida, L., Dimayuga, E. R., Watterson, D. M., & Van Eldik, L. J. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-79 · Cited by 282
Cellular senescence and the aging brain
Chinta, S. J., Woods, G., Rane, A., Demaria, M., Campisi, J., & Andersen, J. K. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2014.09.018 · Cited by 282 · cited 2×
“Therefore, the occurrence of senescent astrocytes in the brain was predicted to contribute to brain decline during aging and accelerate neurological pathologies through the SASP (11, 36, 141).”
Evidence That Aging And Amyloid Promote Microglial Cell Senescence
Flanary, B. E., Sammons, N. W., Nguyen, C., Walker, D., & Streit, W. J. (2007) · Rejuvenation Research · doi:10.1089/rej.2006.9096 · Cited by 272 · cited 1×
“This was confirmed by the observation of telomere shortening; in human brains, which contain high levels of amyloid aggregates, senescent microglia increased in comparison with normal aging brain (53, 54).”
Immune aging, dysmetabolism, and inflammation in neurological diseases
Deleidi, M., Jäggle, M., & Rubino, G. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00172 · Cited by 260 · cited 1×
“As a result of TLR stimulation, microglia can produce the in-flammatory cytokines mentioned above as part of the SASP through NF-j B activation; at the same time, increased mitochondrial ROS production also activates NF-j B (41).”
Senescence-associated secretory phenotype contributes to pathological angiogenesis in retinopathy
Oubaha, M., Miloudi, K., Dejda, A., Guber, V., Mawambo, G., Germain, M.-A., Bourdel, G., Popovic, N., Rezende, F. A., Kaufman, R. J., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf9440 · Cited by 259 · cited 1×
“…to undesired outcomes include age-related illnesses, cancer and NDD (11), tissue disruption and dysfunction (55), chronic inflammation (56, 137), proliferation induction and accelerated tumor growth (24, 88), angiogenesis (129), and differentiation and epithelium– mesenchymal transition (88, 98).”
Autophagy Impairment Induces Premature Senescence in Primary Human Fibroblasts
Kang, H. T., Lee, K. B., Kim, S. Y., Choi, H. R., & Park, S. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023367 · Cited by 254 · cited 1×
“It is now accepted that many stimuli or stressors such as oxidative stress (101), radiation (95), hyperoxia (165), autophagy impairment (83), and proteasome inhibition (163) among others are able to induce the senescence program, independently of cellular replication and telomere attrition.”
Glucocorticoids suppress selected components of the senescence‐associated secretory phenotype
Laberge, R., Zhou, L., Sarantos, M. R., Rodier, F., Freund, A., de Keizer, P. L. J., Liu, S., Demaria, M., Cong, Y., Kapahi, P., et al. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00818.x · Cited by 229
P38 MAP kinase is activated at early stages in Alzheimer's disease brain
Sun, A. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00180-8 · Cited by 219
Alzheimer’s disease as an inflammatory disease
Bolós, M., Perea, J. R., & Avila, J. (2017) · BioMolecular Concepts · doi:10.1515/bmc-2016-0029 · Cited by 216
Stress-induced senescence in human and rodent astrocytes
Bitto, A., Sell, C., Crowe, E., Lorenzini, A., Malaguti, M., Hrelia, S., & Torres, C. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.06.021 · Cited by 204 · cited 4×
“…senescence occurs both in vitro and in vivo (46) and it has been associated with many biological processes such as aging (21), tumor suppression and promotion (23, 137), chronic inflammation (20), embryonic development (118, 156), and recently with neurodegenerative diseases (NDDs) (11, 13, 35).”
InfluentialSelf-citationCytokine Gene Expression as a Function of the Clinical Progression of Alzheimer Disease Dementia
Luterman, J. D., Haroutunian, V., Yemul, S., Ho, L., Purohit, D., Aisen, P. S., Mohs, R., & Pasinetti, G. M. (2000) · Archives of Neurology · doi:10.1001/archneur.57.8.1153 · Cited by 192 · cited 1×
“This hypothesis is supported by articles reporting, in neurons from AD patient tissues, features of senescent phenotype such as p16/CDKN2A expression, increased p38/MAPK activity, IL-6 protein, and TGF-b mRNA expression (103, 104, 111, 158).”
Innate immune receptor expression in normal brain aging
Letiembre, M., Hao, W., Liu, Y., Walter, S., Mihaljevic, I., Rivest, S., Hartmann, T., & Fassbender, K. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.01.004 · Cited by 175
Chinta, S. J., Lieu, C. A., DeMaria, M., Laberge, R. ‐., Campisi, J., & Andersen, J. K. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12029 · Cited by 165 · cited 2×
“…senescence occurs both in vitro and in vivo (46) and it has been associated with many biological processes such as aging (21), tumor suppression and promotion (23, 137), chronic inflammation (20), embryonic development (118, 156), and recently with neurodegenerative diseases (NDDs) (11, 13, 35).”
Alimbetov, D., Davis, T., Brook, A. J. C., Cox, L. S., Faragher, R. G. A., Nurgozhin, T., Zhumadilov, Z., & Kipling, D. (2016) · Biogerontology · doi:10.1007/s10522-015-9610-z · Cited by 162
Biomarkers to identify and isolate senescent cells
Matjusaitis, M., Chin, G., Sarnoski, E. A., & Stolzing, A. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.05.003 · Cited by 144
Senescence-associated beta-galactosidase activity expression in aging hippocampal neurons
Geng, Y.-Q., Guan, J.-T., Xu, X.-H., & Fu, Y.-C. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.05.011 · Cited by 129 · cited 2×
“Accordingly, in vitro studies of primary cortical neurons, derived from various murine models and maintained in culture for a long time, have shown that the average proportion of SA-b -Gal-positive cells augments with time (10, 33, 59).”
Maciel-Barón, L. A., Morales-Rosales, S. L., Aquino-Cruz, A. A., Triana-Martínez, F., Galván-Arzate, S., Luna-López, A., González-Puertos, V. Y., López-Díazguerrero, N. E., Torres, C., & Königsberg, M. (2016) · AGE · doi:10.1007/s11357-016-9886-1 · Cited by 128
Self-citationFrom cellular senescence to Alzheimer’s disease: The role of telomere shortening
Boccardi, V., Pelini, L., Ercolani, S., Ruggiero, C., & Mecocci, P. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.04.003 · Cited by 121
Are there roles for brain cell senescence in aging and neurodegenerative disorders?
Tan, F. C. C., Hutchison, E. R., Eitan, E., & Mattson, M. P. (2014) · Biogerontology · doi:10.1007/s10522-014-9532-1 · Cited by 116 · cited 1×
“In fact, it involves changes in gene expression, epigenetic regulation, alterations in mitochondrial homeostasis, redox state, disruption of energy metabolism and degradation of macromolecules, and multiple changes in cellular metabolism (14, 159).”
Changes in the Transcriptome of Human Astrocytes Accompanying Oxidative Stress-Induced Senescence
Crowe, E. P., Tuzer, F., Gregory, B. D., Donahue, G., Gosai, S. J., Cohen, J., Leung, Y. Y., Yetkin, E., Nativio, R., Wang, L.-S., et al. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00208 · Cited by 110
Self-citationDNA damage in the oligodendrocyte lineage and its role in brain aging
Tse, K.-H., & Herrup, K. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.05.006 · Cited by 108 · cited 1×
“Unrepaired DNA damage has been reported in oligodendrocytes during normal aging, as well as AD, progeroid syndromes, ataxia telangiectasia, and other conditions (4, 169).”
Lüth, H. J., Holzer, M., Gertz, H.-J., & Arendt, T. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02178-2 · Cited by 105 · cited 1×
“This hypothesis is supported by articles reporting, in neurons from AD patient tissues, features of senescent phenotype such as p16/CDKN2A expression, increased p38/MAPK activity, IL-6 protein, and TGF-b mRNA expression (103, 104, 111, 158).”
Golde, T. E., & Miller, V. M. (2009) · Alzheimer's Research & Therapy · doi:10.1186/alzrt5 · Cited by 98 · cited 1×
“Thepotential existence of a neuronal SASP has important physiological implications because chronic and low-grade inflammation (inflammaging) has been associated with neurodegeneration in aging (55, 60).”
Dasgupta, J., Kar, S., Liu, R., Joseph, J., Kalyanaraman, B., Remington, S. J., Chen, C., & Melendez, J. A. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22193 · Cited by 90
Telomeres Shorten with Age in Rat Cerebellum and Cortex in vivo
Flanary, B. E., & Streit, W. J. (2003) · Journal of Anti-Aging Medicine · doi:10.1089/109454503323028894 · Cited by 85
Repeated Lipopolysaccharide Stimulation Induces Cellular Senescence in BV2 Cells
Yu, H.-M., Zhao, Y.-M., Luo, X.-G., Feng, Y., Ren, Y., Shang, H., He, Z.-Y., Luo, X.-M., Chen, S.-D., & Wang, X.-Y. (2012) · Neuroimmunomodulation · doi:10.1159/000330254 · Cited by 76
Redox Control of the Senescence Regulator Interleukin-1α and the Secretory Phenotype
McCarthy, D. A., Clark, R. R., Bartling, T. R., Trebak, M., & Melendez, J. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.493841 · Cited by 73 · cited 1×
“This redox-dependent expression and subsequent processing of IL-1 a provide a therapeutic avenue to limit the activity of this central SASP regulator (110) (Fig.”
Dilley, T. K., Bowden, G. T., & Chen, Q. M. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00308-2 · Cited by 64 · cited 1×
“Conversely, an acknowledged common feature in all described types of senescence is a shift to a pro-oxidant redox state (45, 80, 108, 116), as illustrated in the signaling pathways described above.”
Responses of human embryonic stem cells and their differentiated progeny to ionizing radiation
Zou, Y., Zhang, N., Ellerby, L. M., Davalos, A. R., Zeng, X., Campisi, J., & Desprez, P.-Y. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.08.043 · Cited by 41
Cited by
Evidence and perspectives of cell senescence in neurodegenerative diseases
Si, Z., Sun, L., & Wang, X. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111327 · Cited by 105
Inflammation as common link to progressive neurological diseases
Dias-Carvalho, A., Sá, S. I., Carvalho, F., Fernandes, E., & Costa, V. M. (2024) · Archives of Toxicology · doi:10.1007/s00204-023-03628-8 · Cited by 60
Innate immunity and cellular senescence: The good and the bad in the developmental and aged brain
Santoro, A., Spinelli, C. C., Martucciello, S., Nori, S. L., Capunzo, M., Puca, A. A., & Ciaglia, E. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0118-003r · Cited by 50
Cellular senescence as a driver of cognitive decline triggered by chronic unpredictable stress
Lin, Y.-F., Wang, L.-Y., Chen, C.-S., Li, C.-C., & Hsiao, Y.-H. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100341 · Cited by 47
Molecular Mechanisms of Cellular Senescence in Neurodegenerative Diseases
Lee, H.-J., Yoon, Y.-S., & Lee, S.-J. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168114 · Cited by 36
Metadata
- Authors
- Maciel-Barón, L. Á., Moreno-Blas, D., Morales-Rosales, S. L., González-Puertos, V. Y., López-Díazguerrero, N. E., Torres, C., Castro-Obregón, S., & Königsberg, M.
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2018-06-20
- Volume
- 28
- Issue
- 18
- Pages
- 1704-1723
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- OpenAlex
- W2610789056
- Cited by
- 45
- References
- 78
- FWCI
- 1.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.